Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 6789.73% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 615.87K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 615.87K.
Fairly Valued
The company’s latest PE is -0.62, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 292.25K shares, increasing 33.05% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 31.00K shares of this stock.